ReviewTargeted oncology2026

Claudin-18.2 in Gastric and Gastroesophageal Junction Adenocarcinoma: From Biology to Therapeutic Targeting: A Narrative Review.

Robin Grellet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.